Protection by hot water extract of Panax notoginseng on chronic ethanol-induced hepatotoxicity

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 台中附設醫院 > 期刊論文 > Item 310903500/30221

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/30221

题名:	Protection by hot water extract of Panax notoginseng on chronic ethanol-induced hepatotoxicity
作者:	Lin, CF;Wong, KL;Wu, RSC;Huang, TC;Liu, CF
贡献者:	附設醫院麻醉部;Natl Taipei Coll Nursing, Taipei, Taiwan;China Med Coll Hosp, Dept Anesthesiol, Taichung, Taiwan;Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan
日期:	2003
上传时间:	2010-09-24 14:51:23 (UTC+8)
出版者:	JOHN WILEY & SONS LTD
摘要:	OBJECTIVES: Intranasal corticosteroid preparations can relieve symptoms of allergic rhinitis. Different aqueous corticosteroid forms have been developed for intranasal use. The objectives of this study were to compare efficacy and safety between fluticasone propionate and budesonide in the treatment for patients with allergic rhinitis. METHODS: The study was conducted in a prospective and randomized manner; a total of 24 adult patients were enrolled. All patients received MAST allergen test at entry and again at 2 months after treatments. Fourteen patients received fluticasone propionate 200 mug once daily, and 10 patients received budesonide 200 mug twice daily. To investigate the efficacy of fluticasone propionate and budesonide, a subjective scoring system was designed to evaluate the symptom improvement of patients. Adverse events were recorded on a diary card then were analyzed. Mann-Whitney U test and Kruskal-Wallis 1-way analysis of variance were used for statistical analysis. RESULTS: Analysis on patient-based symptom scores revealed that both fluticasone propionate and budesonide were equally efficacious in improving the symptoms of nasal blockage, sneezing, nasal itching, and watery rhinorrhea. There were no significant side effects reported for both groups during this follow-up period. However, analysis showed that the fluticasone propionate group demonstrated significantly greater improvement in some MAST allergen tests (Candida, mite, house dust; P < 0.05). CONCLUSION: Clinically, fluticasone propionate 200 mug once daily was efficacious as budesonide 200 mug twice daily in the relief of allergic rhinitis symptoms. However, fluticasone propionate can achieve greater immunologic improvement. Both preparations showed no evidence of short-term side effects.
關聯:	PHYTOTHERAPY RESEARCH 17(9):1119-1122
显示于类别:	[台中附設醫院] 期刊論文

文件中的档案:

没有与此文件相关的档案.

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....